We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $812M
1-Year Est. Return 29.76%
This Fund
S&P 500
This Quarter Est. Return
+0.06%
1 Year Est. Return
+29.76%
3 Year Est. Return
+77.21%
5 Year Est. Return
+92.54%
10 Year Est. Return
+280.51%
AUM
$147M
AUM Growth
+$29.5M
Cap. Flow
+$30.7M
Cap. Flow %
20.86%
Top 10 Hldgs %
20.1%
Holding
558
New
454
Increased
48
Reduced
28
Closed
5

Sector Composition

Rank Sector Weight
1 Consumer Staples 19.81%
2 Financials 15.28%
3 Healthcare 14.73%
4 Industrials 8.26%
5 Consumer Discretionary 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVX icon
126
Chevron
CVX
$382B
$153K 0.1%
+1,591
New +$167K
IEMG icon
127
iShares Core MSCI Emerging Markets ETF
IEMG
$144B
$150K 0.1%
+3,124
New +$158K
MRO
128
DELISTED
Marathon Oil Corporation
MRO
$150K 0.1%
+5,660
New +$160K
VHT icon
129
Vanguard Health Care ETF
VHT
$18.5B
$148K 0.1%
+1,060
New +$146K
WFC icon
130
Wells Fargo
WFC
$254B
$148K 0.1%
+2,643
New +$147K
CL icon
131
Colgate-Palmolive
CL
$74.8B
$130K 0.09%
+2,000
New +$136K
IWS icon
132
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
$130K 0.09%
+1,767
New +$133K
NKE icon
133
Nike
NKE
$64.1B
$130K 0.09%
+2,420
New +$124K
SCHC icon
134
Schwab International Small-Cap Equity ETF
SCHC
$5.28B
$130K 0.09%
+4,184
New +$133K
BCS.PRD.CL
135
DELISTED
Barclays Bank Plc
BCS.PRD.CL
$129K 0.09%
+5,000
New +$130K
KMB icon
136
Kimberly-Clark
KMB
$37.6B
$121K 0.08%
+1,145
New +$125K
REGN icon
137
Regeneron Pharmaceuticals
REGN
$72.9B
$114K 0.08%
+225
New +$110K
EFA icon
138
iShares MSCI EAFE ETF
EFA
$76.4B
$111K 0.08%
+1,753
New +$117K
IBB icon
139
iShares Biotechnology ETF
IBB
$9.45B
$111K 0.08%
+903
New +$108K
DUK icon
140
Duke Energy
DUK
$101B
$106K 0.07%
+1,505
New +$114K
C icon
141
Citigroup
C
$213B
$105K 0.07%
+3,024
New +$165K
SUB icon
142
iShares Short-Term National Muni Bond ETF
SUB
$11.3B
$105K 0.07%
+1,000
New +$106K
PEP icon
143
PepsiCo
PEP
$196B
$104K 0.07%
+1,116
New +$107K
GLD icon
144
SPDR Gold Trust
GLD
$131B
$103K 0.07%
+925
New +$106K
SR icon
145
Spire
SR
$4.79B
$102K 0.07%
+1,971
New +$103K
ANDE icon
146
Andersons Inc
ANDE
$2.39B
$94K 0.06%
+2,434
New +$104K
GAP
147
The Gap Inc
GAP
$7.3B
$94K 0.06%
+2,463
New +$97.3K
DST
148
DELISTED
DST Systems Inc.
DST
$94K 0.06%
+1,506
New +$89.3K
OXY icon
149
Occidental Petroleum
OXY
$55.7B
$93K 0.06%
+1,201
New +$93.8K
TWX
150
DELISTED
Time Warner Inc
TWX
$90K 0.06%
+1,016
New +$86.7K

Similar funds

Kavar Capital Partners Group's Q2 2015 Portfolio in Review

As of Q2 2015, Kavar Capital Partners Group held 558 positions worth $147M, up 25% from $118M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Kavar Capital Partners Group deployed $30.7M of net new capital in Q2 2015, opening 454 new positions and adding to 48 existing holdings. Its largest new stake was Reynolds American Inc: 55,750 shares worth $2.08M.

By sector, the portfolio is most concentrated in Consumer Staples at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was CVS Health, an estimated $71.4K trimmed.

  • Kavar Capital Partners Group's largest Q2 2015 buy was Reynolds American Inc: 55,750 shares worth $2.08M.
  • Kavar Capital Partners Group added most to Target in Q2 2015, an estimated $821K increase.
  • Kavar Capital Partners Group's biggest Q2 2015 reduction was CVS Health, cutting an estimated $71.4K.
  • Kavar Capital Partners Group fully exited Steris in Q2 2015, selling an estimated $1.3M.
  • Kavar Capital Partners Group's ten largest holdings make up 20% of its $147M portfolio in Q2 2015.
  • Kavar Capital Partners Group opened 454 new positions and closed 5 in Q2 2015.
  • Kavar Capital Partners Group's portfolio value rose 25% quarter-over-quarter to $147M.

Based on Kavar Capital Partners Group's 13F filing for Q2 2015, filed 1 May 2019.